Research Articles

by Dr Nadia Tsao

08 Nov 2022

Medical Devices for Remote Patient Monitoring of Chronic Conditions

Rising healthcare costs, an aging population and an increasing prevalence of chronic diseases are driving the uptake of remote patient monitoring (RPM) technologies. In their recent report, Remote Patient Monitoring 2023 - 2033: Technologies, Markets and Opportunities, IDTechEx forecasts the market for medical devices supporting RPM to reach US$45 billion by 2033.
02 Nov 2022

Trends in Point of Care Diagnostics and Continuous Monitoring

IDTechEx Reflects on Trends in 2022. For the past decade, the healthcare industry has looked towards decentralization as a means of relieving the pressure placed on healthcare systems.
27 Sep 2022

IDTechEx Report Examines Device Trends in Remote Patient Monitoring

Remote patient monitoring (RPM), referring to the use of technology to measure and transmit physiologic data beyond traditional healthcare settings, has emerged as a promising solution to drive down healthcare costs while maintaining a high standard of care for patients.
07 Oct 2021

Oncology Is a Major Focus for Many AI Drug Discovery Companies

The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients.
18 Aug 2021

AI in Drug Discovery Requires Extensive Chemical Libraries

AI in drug discovery is a field that has received an immense increase in interest, uptake, and investment over the past year due to the COVID-19 pandemic. While lockdowns forced everyone around the world to explore virtual ways of working, the biopharma industry faced the additional task of quickly developing new drugs for the treatment of COVID-19. Enter the application of AI in drug discovery - a technology that promises to drastically cut down timelines and costs, and potentially, develop safer and more efficacious drugs.
10 Jun 2021

AI in Drug Discovery Cuts Timelines From 5+ Years to Months

AI has been successfully applied to speed up virtual screening, de novo drug discovery, and can be utilized to optimize compounds to have drug-like properties. Processes that typically take several years can be reduced to a matter of months.
09 Apr 2021

Antimicrobial Technologies - How Do They Work?

Antimicrobial technologies such as coatings and textiles containing silver and copper are helping people during the COVID-19 pandemic by ensuring that whatever they touch, whether that is a door handle or their own mask, is free from live SARS-CoV-2 particles. But how exactly do these antimicrobial technologies work?
09 Mar 2021

Innovations in Antimicrobials: New Methods to Eliminate Microbes

Today, antimicrobial technologies are used around the world in response to the COVID-19 pandemic. Surfaces and products protected by antimicrobial technology can continuously inactivate and kill harmful microorganisms such as the SARS-CoV-2 virus. In this article, IDTechEx highlights three innovative start-ups that are developing next-generation antimicrobial technologies.
Worldwide
11 Feb 2021

COVID-19 Driving Unprecedented Growth for Antimicrobial Industry

COVID-19 is driving 3- and 4-digit growth for antimicrobial companies - this market has received significant attention from governments, industry, and even consumers over the past year (2020) due to the technology's potential to address transmission of COVID-19.
07 Dec 2020

COVID-19 Brings Unprecedented Shifts in Healthcare Technology Adoption

At IDTechEx, we cover emerging technologies and industry trends, and the COVID-19 pandemic has had a direct or indirect impact on all of them. In this article we will describe some of the key roles that these technologies have played in 2020.
17 Nov 2020

Opportunities in Bioelectronic Medicine - Recent Progress

IDTechEx finds significant progress for companies developing non-invasive peripheral nerve stimulation technologies
22 Sep 2020

Flexible Electronics in Wearable Cardiac Monitoring Technologies

IDTechEx forecasts that flexible electronics in cardiac monitoring, deployed in electronic skin patches and electronic textiles, will be a $2 billion market in the year 2030.